scispace - formally typeset
M

Murugesan Sankarganesh

Researcher at Indian Institute of Technology Kanpur

Publications -  43
Citations -  877

Murugesan Sankarganesh is an academic researcher from Indian Institute of Technology Kanpur. The author has contributed to research in topics: Schiff base & Ligand (biochemistry). The author has an hindex of 13, co-authored 37 publications receiving 457 citations. Previous affiliations of Murugesan Sankarganesh include The American College of Financial Services & American College, Madurai.

Papers
More filters
Journal ArticleDOI

Synthesis, spectral, DFT calculation, sensor, antimicrobial and DNA binding studies of Co(II), Cu(II) and Zn(II) metal complexes with 2-amino benzimidazole Schiff base

TL;DR: In this article, the synthesis of Co(II), Cu(II) and Zn(II)-complexes of bidentate Schiff base ligand (L) 2-((1H-Benzo [d]imidazole-4ylimmino) methyl phenol is presented.
Journal ArticleDOI

A Schiff base receptor as a fluorescence turn-on sensor for Ni2+ ions in living cells and logic gate application

TL;DR: A new receptor with easily available “off–on–off” colorimetric and fluorescent responses was synthesized and characterized and exhibited selective and sensitive detection towards Ni2+ ion without having any interference from other tested metal ions.
Journal ArticleDOI

Biologically Active Cu(II), Co(II), Ni(II) and Zn(II) Complexes of Pyrimidine Derivative Schiff Base: DNA Binding, Antioxidant, Antibacterial and In Vitro Anticancer Studies

TL;DR: The antibacterial activity of the ligand (HL) and complexes 1–4 are more active in Bascillus subtilis and the results shows that the ligands (HL), complexes 1-4 are less active in bacterial strains than ligand and complexes 3 & 4.
Journal ArticleDOI

Gold(III) complex from pyrimidine and morpholine analogue Schiff base ligand: Synthesis, characterization, DFT, TDDFT, catalytic, anticancer, molecular modeling with DNA and BSA and DNA binding studies

TL;DR: The results reveal that Au(III) complex shows greater binding ability towards DNA and BSA than the ligand, and based on the least toxic activity of complex has been further discovered by in vivo anticancer study using Ehrlich Ascites Carcinoma (EAC) tumor bearing Swiss albino mice.